Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin GB0009252882
Ticker GSK.L
Company GLAXOSMITHKLINE
Currency £
Price
Aware Investor Index (AII) 1,304.2530
Recommendation STRONG BUY
P/E 17.12
ROE 100.00 %
Capitalization 96,585,368,023 $
Dividend Yield 5.30 %
P/S 2.47
AII Position 5
P/E Position 211
ROE Position 27
Capitalization Position 85
Dividend Yield Position 75
Sales 30,186,000,000 £
10-Year Average Earnings 4,356,000,000 £
Shares Outstanding 4,941,000,000
Equity -68,000,000 £
Dividend per Share 0.8 £
Industry Pharmaceutical
Country Great Britain
GLAXOSMITHKLINE Investor Relations Web Site http://www.gsk.com/investors.html







Sales:

YEAR MONTH AMOUNT
2017 12 30,186,000,000.00 £
2016 12 27,889,000,000.00 £
2015 12 23,923,000,000.00 £
2014 12 23,006,000,000.00 £
2013 12 26,505,000,000.00 £

Earnings:

YEAR MONTH AMOUNT
2017 12 1,532,000,000.00 £
2016 12 912,000,000.00 £
2015 12 8,422,000,000.00 £
2014 12 2,756,000,000.00 £
2013 12 5,436,000,000.00 £
2012 12 4,499,000,000.00 £
2011 12 5,208,000,000.00 £
2010 12 2,961,000,000.00 £
2009 12 6,283,000,000.00 £
2008 12 5,551,000,000.00 £

Equity:

YEAR MONTH AMOUNT
2017 12 -68,000,000.00 £
2016 12 1,124,000,000.00 £
2015 12 5,114,000,000.00 £
2014 12 4,263,000,000.00 £
2013 12 7,812,000,000.00 £
2012 12 6,747,000,000.00 £
2011 12 8,827,000,000.00 £
2010 12 9,745,000,000.00 £
2009 12 10,742,000,000.00 £
2008 12 8,318,000,000.00 £

Shares Outstanding:

YEAR MONTH AMOUNT
2017 12 4,941,000,000
2016 12 4,909,000,000
2015 12 4,888,000,000
2014 12 4,865,000,000
2013 12 4,919,000,000
2012 12 4,913,000,000
2011 12 5,099,000,000
2010 12 5,128,000,000
2009 12 5,108,000,000
2008 12 5,226,000,000

 












Bloomberg News for GLAXOSMITHKLINE:



Google News for GLAXOSMITHKLINE:

Augusta Review - 7 hours ago
Peeling Back the Layers: Valuation Review on GlaxoSmithKline plc ...
Investors are constantly examining different company financial indicators to assess trading opportunities. GlaxoSmithKline plc (GSK.L) ...
Augusta Review - 1 day ago
Glaxosmithkline Plc (GSK.L) See a Dip of -0.71% For the Week
Shares of Glaxosmithkline Plc (GSK.L) have been trending lower over the past five bars, revealing bearish momentum for the shares, as they ...
Hawthorn Caller
Upper Deck or Lower Lounge? Where Are Glaxosmithkline Plc (GSK ...
Glaxosmithkline Plc (GSK.L) shares might have a significant move ahead as the Mass Index volatility reading has dropped below 26.5.
The FinHeadLines
The Return on Assets For GlaxoSmithKline plc ($GSK.L) Placed ...
The Return on Assets for GlaxoSmithKline plc (GSK.L) is 0.064259. This number is calculated by dividing net income after tax by the company's ...
Port Courier
Glaxosmithkline Plc (GSK.L): Pulling the Layers Back For The ...
Tracking shares of Glaxosmithkline Plc (GSK.L), we have seen that the Chaikin Oscillator reading is currently below zero. Traders following the ...
Augusta Review - 1 day ago
United Asset Strategies Has Increased By $1.31 Million Its ...
It has outperformed by 7.61% the S&P500. Some Historical GSK News: 25/04/2018 – GLAXOSMITHKLINE GSK.L NEW R&D HEAD BARRON ...
Augusta Review - 1 day ago
Focusing The Bulls-Eye on Shares Glaxosmithkline Plc (GSK.L)
Glaxosmithkline Plc (GSK.L)'s moving averages reveal that the Tenkan line of the shares are below the Kijun-Sen line, indicating potential ...
Stock News Oracle - 2 days ago
Magic Formula Rank For GlaxoSmithKline plc ($GSK.L$) Placed ...
The MF Rank of GlaxoSmithKline plc (GSK.L) is 812. A company with a low rank is considered a good firm to invest in. The Magic Formula was ...
The FinHeadLines - 1 day ago
Wallace Capital Management Lowered Position in Glaxosmithkline ...
Wallace Capital Management Inc decreased its stake in Glaxosmithkline Plc (GSK) by 16.98% based on its latest 2018Q4 regulatory filing with ...
Stock News Oracle - 3 days ago
Kahn Brothers Group Boosted Glaxosmithkline (GSK) Stake; Toll ...
... 22/03/2018 – GLAXOSMITHKLINE PLC GSK.L : MORGAN STANLEY RAISES TO EQUAL-WEIGHT FROM UNDERWEIGHT; 11/05/2018 ...


Back